KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Non-Current Liabilities (2016 - 2025)

Sarepta Therapeutics (SRPT) has 14 years of Other Non-Current Liabilities data on record, last reported at $36.3 million in Q3 2025.

  • For Q3 2025, Other Non-Current Liabilities fell 23.42% year-over-year to $36.3 million; the TTM value through Sep 2025 reached $36.3 million, down 23.42%, while the annual FY2024 figure was $47.4 million, 24.41% up from the prior year.
  • Other Non-Current Liabilities reached $36.3 million in Q3 2025 per SRPT's latest filing, down from $47.4 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $50.8 million in Q2 2021 and bottomed at $11.0 million in Q1 2022.
  • Average Other Non-Current Liabilities over 5 years is $38.6 million, with a median of $38.1 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Liabilities: soared 307.47% in 2021, then fell 23.42% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $43.6 million in 2021, then dropped by 15.37% to $36.9 million in 2022, then rose by 3.25% to $38.1 million in 2023, then increased by 24.41% to $47.4 million in 2024, then decreased by 23.42% to $36.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $36.3 million in Q3 2025, $47.4 million in Q2 2025, and $47.4 million in Q4 2024.